Schedule 13G ownership disclosure

Praxis Precision Medicines Inc

Common Stock, par value $0.0001 per share · CUSIP: 74006W207

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 1,465,105.00 · Class: 7.0%

  • Point72 Capital Advisors, Inc.

    Shares: 1,465,105.00 · Class: 7.0%

  • Point72 Biotech Private Investments, LLC

    Shares: 65,933.00 · Class: 0.3%

  • Differentiated Ventures Investments, LLC

    Shares: 65,933.00 · Class: 0.3%

  • 72 Investment Holdings, LLC

    Shares: 65,933.00 · Class: 0.3%

  • Steven A. Cohen

    Shares: 1,531,038.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003695
Form type
SCHEDULE 13G/A
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub